All types
All types
News
Press releases - Regulatory
Press releases - Non regulatory
All years
All years
2022
2021
2020
2019
2018
2017
2015
2010
2009
-
Isofol announces its intention to carry out a fully guaranteed preferential rights issue of approximately SEK 400 million and a potential over-allotment option of up to approximately SEK 100 million
Regulatory press releaseGOTHENBURG, Sweden, April 28, 2021 - Isofol Medical AB (publ), (Nasdaq First North Premier Growth…
-
Invitation to a conference call and webcast in connection with Isofol receiving recommendation to complete the global Phase III AGENT study for market registration as planned with 440 patients
Non regulatory press releaseGOTHENBURG, Sweden, March 22, 2021 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier…
-
Isofol announces its intention to carry out a fully guaranteed preferential rights issue of approximately SEK 150 million and a potential over-allotment option of up to approximately SEK 30 million
Regulatory press releaseGOTHENBURG, Sweden, March 30, 2020 - Isofol Medical AB (publ), (Nasdaq First North Premier Growth…
-
SCRIP INTELLIGENCE, A LEADING SOURCE OF NEWS AND STRATEGIC ANALYSIS FOR THE GLOBAL PHARMACEUTICAL INDUSTRY, PUBLISH ARTICLE ABOUT ISOFOL MEDICAL AB’S LEAD CANDIDATE MODUFOLIN®, AND THE UPCOMING PIVOTAL PHASE III STUDY IN METASTATIC COLORECTAL CANCER
NewsJohn Davis, journalist and editor for more than 30 years, of Scrip Intelligence recently interviewed…